Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 11724
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642680(US20230416268, Example 39)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642681(US20230416268, Example 40)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642682(US20230416268, Example 41)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642683(US20230416268, Example 42)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642676(US20230416268, Example 35)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642677(US20230416268, Example 36)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642678(US20230416268, Example 37)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642688(US20230416268, Example 48 | US20230416268, Example...)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642688(US20230416268, Example 48 | US20230416268, Example...)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642690(US20230416268, Example 49)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642684(US20230416268, Example 43)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642687(US20230416268, Example 46)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642664(US20230416268, Example 23)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642665(US20230416268, Example 24)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642666(US20230416268, Example 25)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642667(US20230416268, Example 26)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642660(US20230416268, Example 19)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642661(US20230416268, Example 20)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642662(US20230416268, Example 21)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642663(US20230416268, Example 22)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642672(US20230416268, Example 31)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642673(US20230416268, Example 32)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642674(US20230416268, Example 33)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642675(US20230416268, Example 34)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642668(US20230416268, Example 27)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642669(US20230416268, Example 28)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642670(US20230416268, Example 29)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642671(US20230416268, Example 30)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642715(US20230416268, Example 75)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642708(US20230416268, Example 67)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642709(US20230416268, Example 68)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642710(US20230416268, Example 69)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642711(US20230416268, Example 70)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642720(US20230416268, Example 80)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642721(US20230416268, Example 81)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642722(US20230416268, Example 82)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642723(US20230416268, Example 83)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642717(US20230416268, Example 77)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642719(US20230416268, Example 79)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642697(US20230416268, Example 56)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642692(US20230416268, Example 51)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642694(US20230416268, Example 53)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642704(US20230416268, Example 63)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642705(US20230416268, Example 64)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642706(US20230416268, Example 65)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642707(US20230416268, Example 66)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642701(US20230416268, Example 60)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642703(US20230416268, Example 62)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642731(US20230416268, Example 91)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM642724(US20230416268, Example 84)
Affinity DataIC50: 100nMAssay Description:Recombinant human 17β-HSD13 was expressed and purified from sf9 cells at Charles River Labs (Saffron Walden, UK). Leukotriene B4 (Catalog #71160...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2024
Entry Details
US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: